Yorktown Management & Research Co Inc decreased its position in Perrigo Company PLC (NYSE:PRGO) by 42.8% in the first quarter, according to its most recent Form 13F filing with the SEC. The firm owned 7,900 shares of the company’s stock after selling 5,900 shares during the period. Yorktown Management & Research Co Inc’s holdings in Perrigo were worth $380,000 at the end of the most recent quarter.
Other hedge funds and other institutional investors have also recently made changes to their positions in the company. Moody National Bank Trust Division acquired a new position in shares of Perrigo during the first quarter worth $32,000. Oregon Public Employees Retirement Fund increased its position in shares of Perrigo by 3,574.9% during the fourth quarter. Oregon Public Employees Retirement Fund now owns 1,430,805 shares of the company’s stock worth $37,000 after purchasing an additional 1,391,870 shares in the last quarter. Parallel Advisors LLC grew its holdings in shares of Perrigo by 833.7% during the first quarter. Parallel Advisors LLC now owns 803 shares of the company’s stock valued at $39,000 after buying an additional 717 shares during the last quarter. Advisor Group Inc. grew its holdings in shares of Perrigo by 822.2% during the fourth quarter. Advisor Group Inc. now owns 1,079 shares of the company’s stock valued at $41,000 after buying an additional 962 shares during the last quarter. Finally, Covington Capital Management purchased a new stake in shares of Perrigo during the fourth quarter valued at $46,000. Hedge funds and other institutional investors own 86.02% of the company’s stock.
A number of brokerages have recently weighed in on PRGO. Cantor Fitzgerald dropped their price objective on shares of Perrigo from $107.00 to $60.00 and set an “overweight” rating on the stock in a report on Wednesday, June 12th. SunTrust Banks boosted their price objective on shares of Perrigo to $51.00 and gave the company a “hold” rating in a report on Monday, May 20th. Morgan Stanley dropped their price objective on shares of Perrigo from $67.00 to $54.00 and set an “equal weight” rating on the stock in a report on Tuesday, March 26th. ValuEngine raised shares of Perrigo from a “strong sell” rating to a “sell” rating in a report on Wednesday, March 20th. Finally, Wells Fargo & Co set a $45.00 price target on shares of Perrigo and gave the company a “hold” rating in a report on Wednesday, June 19th. Two investment analysts have rated the stock with a sell rating, ten have issued a hold rating and two have assigned a buy rating to the company. Perrigo currently has a consensus rating of “Hold” and an average target price of $66.38.
Perrigo (NYSE:PRGO) last posted its earnings results on Wednesday, May 8th. The company reported $1.07 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.94 by $0.13. Perrigo had a net margin of 2.43% and a return on equity of 10.40%. The business had revenue of $1.17 billion for the quarter, compared to analyst estimates of $1.15 billion. During the same period in the prior year, the company posted $1.26 EPS. On average, equities research analysts anticipate that Perrigo Company PLC will post 3.92 EPS for the current fiscal year.
The business also recently declared a quarterly dividend, which was paid on Tuesday, June 18th. Investors of record on Friday, May 31st were given a dividend of $0.21 per share. This represents a $0.84 annualized dividend and a dividend yield of 1.76%. The ex-dividend date was Thursday, May 30th. This is an increase from Perrigo’s previous quarterly dividend of $0.19. Perrigo’s dividend payout ratio is 18.46%.
Perrigo Company plc, a healthcare company, manufactures and supplies over-the-counter (OTC) healthcare products, infant formulas, branded OTC products, and generic pharmaceutical products. The company operates through Consumer Healthcare Americas, Consumer Healthcare International, and Prescription Pharmaceuticals segments.
See Also: How to calculate compound interest
Receive News & Ratings for Perrigo Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Perrigo and related companies with MarketBeat.com's FREE daily email newsletter.